Anebulo Pharmaceuticals Ownership 2024 | Who Owns Anebulo Pharmaceuticals Now?

Overview ForecastFinancials Chart

Institutional Ownership

28.18%

Insider Ownership

65.38%

Retail Ownership

6.44%

Institutional Holders

12.00

Anebulo Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
22NW, LP	20.69%	12.50%	5,366,290	-	-	14,649,972	Jun 30, 2024
LVW ADVISORS, LLC	2.48%	0.26%	642,039	-	-	1,752,767	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	1.97%	0.08%	511,073	-	-	1,395,229	Jun 30, 2024
MORGAN STANLEY	1.54%	0.00%	399,219	-	-	1,089,868	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.61%	0.08%	157,862	-	-	430,964	Jun 30, 2024
VANGUARD GROUP INC	0.59%	-	153,873	401	0.26%	420,073	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.20%	-	51,308	28,531	125.26%	140,129	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.07%	0.00%	18,978	-	-	51,810	Jun 30, 2024
BLACKROCK INC.	0.01%	-	3,761	-288	-7.11%	10,267	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	3,300	-1,838	-35.77%	9,009	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	65	65	100.00%	177	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	10	1	11.11%	27	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-62	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-144	-100.00%	-	Jun 30, 2024

Anebulo Pharmaceuticals's largest institutional shareholder is 22NW, LP, holding 20.69% of the company's total share outstanding, currently valued at $14.65M. The top 10 institutional shareholders own together 28.18% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
22NW, LP	20.69%	12.50%	5,366,290	-	-	14,649,972	Jun 30, 2024
LVW ADVISORS, LLC	2.48%	0.26%	642,039	-	-	1,752,767	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	1.97%	0.08%	511,073	-	-	1,395,229	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.61%	0.08%	157,862	-	-	430,964	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.07%	0.00%	18,978	-	-	51,810	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	3,300	-1,838	-35.77%	9,009	Jun 30, 2024
MORGAN STANLEY	1.54%	0.00%	399,219	-	-	1,089,868	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.20%	-	51,308	28,531	125.26%	140,129	Jun 30, 2024
VANGUARD GROUP INC	0.59%	-	153,873	401	0.26%	420,073	Jun 30, 2024
BLACKROCK INC.	0.01%	-	3,761	-288	-7.11%	10,267	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	65	65	100.00%	177	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	10	1	11.11%	27	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-62	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-144	-100.00%	-	Jun 30, 2024

The largest Anebulo Pharmaceuticals shareholder by % of total assets is 22NW, LP. The company owns 5.37M shares of Anebulo Pharmaceuticals (ANEB), representing 12.50% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	0.20%	-	51,308	28,531	125.26%	140,129	Jun 30, 2024
VANGUARD GROUP INC	0.59%	-	153,873	401	0.26%	420,073	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	65	65	100.00%	177	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	10	1	11.11%	27	Jun 30, 2024
MORGAN STANLEY	1.54%	0.00%	399,219	-	-	1,089,868	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.07%	0.00%	18,978	-	-	51,810	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.61%	0.08%	157,862	-	-	430,964	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	1.97%	0.08%	511,073	-	-	1,395,229	Jun 30, 2024
LVW ADVISORS, LLC	2.48%	0.26%	642,039	-	-	1,752,767	Jun 30, 2024
22NW, LP	20.69%	12.50%	5,366,290	-	-	14,649,972	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-62	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-144	-100.00%	-	Jun 30, 2024
BLACKROCK INC.	0.01%	-	3,761	-288	-7.11%	10,267	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	3,300	-1,838	-35.77%	9,009	Jun 30, 2024

As of Jun 30 2024, Anebulo Pharmaceuticals's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 28.53K stocks of ANEB, valued at $140.13K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	3,300	-1,838	-35.77%	9,009	Jun 30, 2024
BLACKROCK INC.	0.01%	-	3,761	-288	-7.11%	10,267	Jun 30, 2024
UBS GROUP AG	-	-	-	-144	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-62	-100.00%	-	Jun 30, 2024
22NW, LP	20.69%	12.50%	5,366,290	-	-	14,649,972	Jun 30, 2024
LVW ADVISORS, LLC	2.48%	0.26%	642,039	-	-	1,752,767	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	1.97%	0.08%	511,073	-	-	1,395,229	Jun 30, 2024
IKARIAN CAPITAL, LLC	0.61%	0.08%	157,862	-	-	430,964	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	0.07%	0.00%	18,978	-	-	51,810	Jun 30, 2024
MORGAN STANLEY	1.54%	0.00%	399,219	-	-	1,089,868	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	10	1	11.11%	27	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	65	65	100.00%	177	Jun 30, 2024
VANGUARD GROUP INC	0.59%	-	153,873	401	0.26%	420,073	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.20%	-	51,308	28,531	125.26%	140,129	Jun 30, 2024

As of Jun 30 2024, Anebulo Pharmaceuticals's biggest institutional seller is TOWER RESEARCH CAPITAL LLC (TRC). The company sold -1.84K shares of ANEB, valued at $9.01K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	-	-	-	-144	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-62	-100.00%	-	Jun 30, 2024

Anebulo Pharmaceuticals's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -0.14K shares, valued at -, as of undefined.

Anebulo Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	153,472	87,643	133.14%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	7,407	1,420	23.72%	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	264	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	366	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	636	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	3,683	-96	-2.54%	Mar 31, 2024

Anebulo Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 153.47K shares, compromising 0.00% of its total assets.

Anebulo Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	12	-14.29%
31 Mar, 24	14	7.69%
31 Dec, 23	13	18.18%
30 Sep, 23	11	-
30 Jun, 23	11	22.22%
31 Mar, 23	9	-25.00%
31 Dec, 22	12	20.00%
30 Sep, 22	10	25.00%
30 Jun, 22	8	-
31 Mar, 22	8	-
31 Dec, 21	8	14.29%
30 Sep, 21	7	-12.50%
30 Jun, 21	8	-

As of 30 Jun 24, 12 institutions are holding Anebulo Pharmaceuticals's shares, representing a decrease of -14.29% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	7,307,778	0.02%
31 Mar, 24	7,306,365	0.38%
31 Dec, 23	7,278,993	3.24%
30 Sep, 23	7,050,491	0.26%
30 Jun, 23	7,031,883	2.86%
31 Mar, 23	6,836,130	-2.98%
31 Dec, 22	7,046,307	2.97%
30 Sep, 22	6,842,912	46.28%
30 Jun, 22	4,677,847	11.63%
31 Mar, 22	4,190,412	-0.07%
31 Dec, 21	4,193,307	0.24%
30 Sep, 21	4,183,214	-0.40%
30 Jun, 21	4,199,876	-

Anebulo Pharmaceuticals (ANEB) has 7.31M shares outstanding as of 30 Jun 24, up 0.02% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	28.18%	3.51%
31 Mar, 24	28.33%	3.56%
31 Dec, 23	28.22%	3.57%
30 Sep, 23	28.12%	3.74%
30 Jun, 23	27.43%	3.86%
31 Mar, 23	26.67%	3.53%
31 Dec, 22	27.49%	3.22%
30 Sep, 22	29.22%	7.28%
30 Jun, 22	20.04%	6.22%
31 Mar, 22	17.95%	5.56%
31 Dec, 21	17.96%	5.59%
30 Sep, 21	17.92%	3.40%
30 Jun, 21	22.96%	-

As of 30 Jun 24, Anebulo Pharmaceuticals is held by 28.18% institutional shareholders, representing a 3.51% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	4	-33.33%
31 Mar, 24	6	-14.29%
31 Dec, 23	7	40.00%
30 Sep, 23	5	25.00%
30 Jun, 23	4	33.33%
31 Mar, 23	3	-25.00%
31 Dec, 22	4	-
30 Sep, 22	4	33.33%
30 Jun, 22	3	-
31 Mar, 22	3	-
31 Dec, 21	3	200.00%
30 Sep, 21	1	-87.50%
30 Jun, 21	8	-

4 institutional shareholders have increased their position in ANEB stock as of 30 Jun 24 compared to 6 in the previous quarter (a -33.33% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	2	-33.33%
31 Mar, 24	3	-
31 Dec, 23	3	50.00%
30 Sep, 23	2	-
30 Jun, 23	2	100.00%
31 Mar, 23	1	-66.67%
31 Dec, 22	3	-40.00%
30 Sep, 22	5	400.00%
30 Jun, 22	1	-66.67%
31 Mar, 22	3	50.00%
31 Dec, 21	2	-50.00%
30 Sep, 21	4	-
30 Jun, 21	-	-

2 institutional shareholders have reduced their position in ANEB stock as of 30 Jun 24 compared to 3 in the previous quarter (a -33.33% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	12	-14.29%	7,307,778	0.02%	28.18%	3.51%	4	-33.33%	2	-33.33%
31 Mar, 24	14	7.69%	7,306,365	0.38%	28.33%	3.56%	6	-14.29%	3	-
31 Dec, 23	13	18.18%	7,278,993	3.24%	28.22%	3.57%	7	40.00%	3	50.00%
30 Sep, 23	11	-	7,050,491	0.26%	28.12%	3.74%	5	25.00%	2	-
30 Jun, 23	11	22.22%	7,031,883	2.86%	27.43%	3.86%	4	33.33%	2	100.00%
31 Mar, 23	9	-25.00%	6,836,130	-2.98%	26.67%	3.53%	3	-25.00%	1	-66.67%
31 Dec, 22	12	20.00%	7,046,307	2.97%	27.49%	3.22%	4	-	3	-40.00%
30 Sep, 22	10	25.00%	6,842,912	46.28%	29.22%	7.28%	4	33.33%	5	400.00%
30 Jun, 22	8	-	4,677,847	11.63%	20.04%	6.22%	3	-	1	-66.67%
31 Mar, 22	8	-	4,190,412	-0.07%	17.95%	5.56%	3	-	3	50.00%
31 Dec, 21	8	14.29%	4,193,307	0.24%	17.96%	5.59%	3	200.00%	2	-50.00%
30 Sep, 21	7	-12.50%	4,183,214	-0.40%	17.92%	3.40%	1	-87.50%	4	-
30 Jun, 21	8	-	4,199,876	-	22.96%	-	8	-	-	-

Anebulo Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 20, 2023	English Aron R.	director, 10 percent owner		G-Gift	Sell	300,000	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 17, 2024	Lin Kenneth	director	-	A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	Lin Kenneth	director	-	A-Award	Buy	2,482	$2.10	$5.21K	2,482
Jun 17, 2024	Calloway Nathaniel	director	-	A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	Calloway Nathaniel	director	-	A-Award	Buy	1,655	$2.10	$3.48K	1,655
Jun 17, 2024	Kupchyk Areta	director	-	A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	Kupchyk Areta	director	-	A-Award	Buy	1,324	$2.10	$2.78K	1,324
Jun 17, 2024	Lawler Joseph F.	director	-	A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	Lawler Joseph F.	director	-	A-Award	Buy	6,618	$2.10	$13.90K	6,618
Jun 17, 2024	English Aron R.	director, 10 percent owner		A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	English Aron R.	director, 10 percent owner		A-Award	Buy	1,324	$2.10	$2.78K	1,324
Jun 17, 2024	SHAH BIMAL R.	director	-	A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	SHAH BIMAL R.	director	-	A-Award	Buy	3,309	$2.10	$6.95K	3,309
Jun 17, 2024	Aryeh Jason	director	-	A-Award	Buy	41,667	$2.10	$87.50K	41,667
Jun 17, 2024	Aryeh Jason	director	-	A-Award	Buy	2,482	$2.10	$5.21K	2,482
Mar 08, 2024	Cundy Kenneth C	officer	Chief Scientific Officer	A-Award	Buy	72,613	$2.72	$197.51K	72,613
Mar 01, 2024	Cundy Kenneth C	officer	Chief Scientific Officer	A-Award	Buy	72,613	$2.78	$201.86K	72,613
Dec 20, 2023	English Aron R.	director, 10 percent owner		G-Gift	Buy	300,000	-	-	5,366,290
Dec 20, 2023	English Aron R.	director, 10 percent owner		A-Award	Buy	300,000	-	-	300,000
Dec 20, 2023	English Aron R.	director, 10 percent owner		G-Gift	Sell	300,000	-	-	-
Oct 11, 2023	Cunningham, Richard Anthony	director, officer	Chief Executive Officer	A-Award	Buy	600,000	$3.03	$1.82M	600,000

The last insider sell of Anebulo Pharmaceuticals's stock was made by English Aron R. on Dec 20 2023, selling 300,000 shares at - per share (valued at -).

Anebulo Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	1	-	-
Q4 2023	4	1	400.00%
Q3 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	3	-	-
Q2 2022	8	-	-
Q1 2022	1	-	-
Q4 2021	4	-	-
Q2 2021	2	8	25.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Anebulo Pharmaceuticals's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	4	-	-
Q2 2021	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Anebulo Pharmaceuticals's stocks.

Anebulo Pharmaceuticals Peer Ownership

Ticker	Company
ANAB	AnaptysBio, Inc.
PMVP	PMV Pharmaceuticals, Inc.
MLYS	Mineralys Therapeutics, Inc.
AVTE	Aerovate Therapeutics, Inc.
ACRV	Acrivon Therapeutics, Inc. Common Stock
ANTX	AN2 Therapeutics, Inc.
ADAG	Adagene Inc.
MOLN	Molecular Partners AG
OPT	Opthea Limited

ANEB Ownership FAQ

Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals is owned by institutional shareholders (28.18%), insiders (65.38%), and public (6.44%). The largest institutional shareholder of Anebulo Pharmaceuticals is 22NW, LP (20.69% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals's major institutional shareholders are 22NW, LP, LVW ADVISORS, LLC, NANTAHALA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and IKARIAN CAPITAL, LLC. The top five shareholders own together 27.29% of the company's share outstanding.

How many Anebulo Pharmaceuticals shareholders are there?

As of Jun 2024, there are 12 institutional shareholders of Anebulo Pharmaceuticals.

What percentage of Anebulo Pharmaceuticals is owned by 22NW, LP?

22NW, LP owns 5.37M shares of Anebulo Pharmaceuticals, representing 20.69% of the company's total shares outstanding, valued at $14.65M (as of Jun 2024).

What percentage of Anebulo Pharmaceuticals is owned by LVW ADVISORS, LLC?

As of Jun 2024, LVW ADVISORS, LLC holds 642.04K shares of Anebulo Pharmaceuticals (ANEB), compromising 2.48% of the company, valued at $1.75M.

What percentage of Anebulo Pharmaceuticals is owned by NANTAHALA CAPITAL MANAGEMENT, LLC?

NANTAHALA CAPITAL MANAGEMENT, LLC is the third largest holder of Anebulo Pharmaceuticals. The company owns 511.07K of the company's shares outstanding (worth $1.4M).